Genetic variation that raises risk of serious complication linked to osteoporosis drugs identified
Researchers have identified a genetic variation that raises the risk of developing serious necrotic jaw bone lesions in patients who take bisphosphonates, a common class of osteoclastic inhibitors.
No comments:
Post a Comment